These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1779634)

  • 21. Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma.
    Arn PH; Hauser ER; Thomas GH; Herman G; Hess D; Brusilow SW
    N Engl J Med; 1990 Jun; 322(23):1652-5. PubMed ID: 2342525
    [No Abstract]   [Full Text] [Related]  

  • 22. Carrier detection in ornithine transcarbamylase deficiency.
    Hokanson JT; O'Brien WE; Idemoto J; Schafer IA
    J Pediatr; 1978 Jul; 93(1):75-8. PubMed ID: 650350
    [No Abstract]   [Full Text] [Related]  

  • 23. Valproate-induced hyperammonemia in asymptomatic children.
    Wyllie E; Wyllie R; Rothner AD; Erenberg G; Cruse RP
    Cleve Clin Q; 1983; 50(3):275-7. PubMed ID: 6418412
    [No Abstract]   [Full Text] [Related]  

  • 24. [The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].
    Matsui K; Iwamoto H; Ohtsuki N; Kobayashi T; Miyake S; Yamada M
    No To Hattatsu; 1991 Jan; 23(1):32-8. PubMed ID: 1825272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An inherited enzyme deficiency resulting in hyperammonaemia and coma in a burn patient.
    Field TO; Dominic WJ; Hansbrough JF
    Burns Incl Therm Inj; 1987 Jun; 13(3):229-31. PubMed ID: 3607566
    [No Abstract]   [Full Text] [Related]  

  • 26. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs.
    Thom H; Carter PE; Cole GF; Stevenson KL
    Dev Med Child Neurol; 1991 Sep; 33(9):795-802. PubMed ID: 1936631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
    Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P
    Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198
    [No Abstract]   [Full Text] [Related]  

  • 28. Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient.
    Heringlake S; Böker K; Manns M
    Digestion; 1997; 58(1):83-6. PubMed ID: 9018015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic counseling in ornithine carbamoyltransferase deficiency].
    Pelet A; Toumas E; Rabier D; Kaplan J; Kamoun P; Frezal J; Saudubray JM; Munnich A
    Ann Biol Clin (Paris); 1988; 46(7):455-9. PubMed ID: 2903704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma alpha-ketoglutarate in urea cycle enzymopathies and its role as a harbinger of hyperammonemic coma.
    Batshaw ML; Walser M; Brusilow SW
    Pediatr Res; 1980 Dec; 14(12):1316-9. PubMed ID: 7208146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lethal ornithine transcarbamylase deficiency in a female neonate: a new case.
    Klosowski S; Largilliere C; Storme L; Rakza T; Rabier D; Lequien P
    Acta Paediatr; 1998 Feb; 87(2):227-8. PubMed ID: 9512214
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?].
    Ettlin T; Scollo-Lavizzari G
    Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids.
    Lipskind S; Loanzon S; Simi E; Ouyang DW
    J Perinatol; 2011 Oct; 31(10):682-4. PubMed ID: 21956151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperammonaemic encephalopathy induced by a commercial very-low-energy diet in a neglected ornithine-carbamoyltransferase-deficient woman.
    Vinzio S; Perrin AE; Forestier E; Schlienger JL; Goichot B
    J Inherit Metab Dis; 2005; 28(6):1133-5. PubMed ID: 16435206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary hyperammonaemic syndromes--a six year experience.
    Haan EA; Danks DM; Hoogenraad NJ; Rogers JG
    Aust Paediatr J; 1979 Sep; 15(3):142-6. PubMed ID: 518407
    [No Abstract]   [Full Text] [Related]  

  • 36. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
    Coulter DL; Allen RJ
    Lancet; 1980 Jun; 1(8181):1310-1. PubMed ID: 6104123
    [No Abstract]   [Full Text] [Related]  

  • 37. [Partial ornithine carbamyl transferase deficiency].
    Largillière C
    Pediatrie; 1988; 43(4):309-12. PubMed ID: 3419873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy of urea cycle enzymopathies: three case studies.
    Batshaw ML; Painter MJ; Sproul GT; Schafer IA; Thomas GH; Brusilow S
    Johns Hopkins Med J; 1981 Jan; 148(1):34-40. PubMed ID: 7453005
    [No Abstract]   [Full Text] [Related]  

  • 39. Valproate acute administration, EEG epileptic abnormalities, and ammonemia.
    Sannita WG
    Neurology; 1992 Oct; 42(10):2003-5. PubMed ID: 1407583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial expression of ornithine transcarbamylase deficiency in an Egyptian female carrier.
    Al-Haggar M; Largiadèr CR; Abdel-Hady D; Barakat T; Nuoffer JM; Al-Refaei AA
    Int J Gynaecol Obstet; 2014 Feb; 124(2):174-5. PubMed ID: 24268225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.